Dimensional Fund Advisors LP Syros Pharmaceuticals, Inc. Transaction History

Dimensional Fund Advisors LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.69 - $1.21 $152,538 - $267,495	-221,071 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.02 - $3.8 $96,006 - $357,671	-94,124 Reduced 29.86%	221,071 $263,000
Q4 2021 Feb 09, 2022	BUY	$3.26 - $4.66 $358,247 - $512,096	109,892 Added 53.53%	315,195 $1.03 Million
Q3 2021 Nov 12, 2021	SELL	$4.08 - $5.66 $421,659 - $584,949	-103,348 Reduced 33.48%	205,303 $918,000
Q2 2021 Aug 12, 2021	SELL	$5.01 - $7.48 $213,015 - $318,034	-42,518 Reduced 12.11%	308,651 $1.68 Million
Q1 2021 May 14, 2021	SELL	$7.19 - $14.95 $1.11 Million - $2.3 Million	-153,910 Reduced 30.47%	351,169 $2.63 Million
Q4 2020 Feb 25, 2021	BUY	$6.66 - $14.66 $3.36 Million - $7.4 Million	505,079 New	505,079 $5.48 Million

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.